Optical studies of drug-protein complexes. V. The interaction of phenylbutazone, flufenamic acid, and dicoumarol with acetylsalicylic acid-treated human serum albumin.
D000085:Acetates; D000215:Acylation; D000812:Anhydrides; D000893:Anti-Inflammatory Agents; D000941:Antigens; D001241:Aspirin / Q000009:adverse effects; D001665:Binding Sites; D055598:Chemical Phenomena; D002621:Chemistry; D002942:Circular Dichroism; D003956:Dialysis; D001728:Dicumarol; D004361:Drug Tolerance; D005439:Flufenamic Acid; D005453:Fluorescence; D005461:Fluorine; D005998:Glycine; D006801:Humans; D008433:Mathematics; D009905:Optical Rotatory Dispersion; D010400:Penicillin G; D010653:Phenylbutazone; D011485:Protein Binding / Q000187:drug effects; D012709:Serum Albumin; D013451:Sulfonic Acids; D013997:Time Factors; D014466:Ultraviolet Rays; D062367:ortho-Aminobenzoates
D000085:Acetates; D000812:Anhydrides; D000893:Anti-Inflammatory Agents; D000941:Antigens; D012709:Serum Albumin; D013451:Sulfonic Acids; D062367:ortho-Aminobenzoates; D005461:Fluorine; D005439:Flufenamic Acid; D001728:Dicumarol; D010653:Phenylbutazone; D010400:Penicillin G; D001241:Aspirin; D005998:Glycine